All Articles

LightPath Technologies' Russell 3000 inclusion is no accident. It's a story of operational innovation and vertical integration in a critical sector.

More than a move, the new facility is a strategic play in Middle Georgia's booming market, redefining patient care and signaling a new era of healthcare investment.

A new collaboration allows investors to buy yield-bearing digital gold like a stock, marking a pivotal moment in the fusion of traditional finance and blockchain.

A $49M government-backed loan sends a Connecticut company’s stock soaring. Is this the future of American clean energy or a risky taxpayer-funded gamble?

MDJM Ltd. appoints a top sinologist for its ambitious Fernie Castle project, a high-stakes bet that academic rigor can build a bridge between Eastern philosophy and Western commerce.

The firm is on the cusp of controlling 5% of all ETH, a strategic accumulation that signals a new era of institutional power on the Ethereum network.

A new partnership brings AI surveillance to 700+ lots, promising enhanced safety but raising critical questions about privacy and public trust.

Niobrara Capital's partnership with WovenLight ditches traditional consulting, embedding AI and capital to forge a new, risk-sharing model for private equity.

As AI adoption soars, most companies can't measure its true value. A new partnership between Unisys and Antenna promises to change that. Here's why.

A power solutions firm says its new generators are for our AI-driven lives. As it pushes into the US, can a smart strategy overcome harsh market realities?

Almadex Minerals' $500K sale of its El Cobre royalty is more than a minor transaction; it's a calculated move to fund its US exploration pipeline.

Almonty Industries' inclusion in the Russell 1000 is more than a stock market milestone. It validates a strategy built at the nexus of profit and geopolitics.

A landmark real-world study shows an 83.5% response rate for PTSD in patients with comorbid depression, signaling a potential paradigm shift for a notoriously hard-to-treat population.

With its fibromyalgia drug now on the market, Tonix is expanding its use to MDD, targeting disturbed sleep in a novel approach for millions of patients.

With a C$1.47M treasury boost and strong shareholder alignment, Forte Minerals is poised to aggressively advance its Peruvian copper and gold projects.

A new partnership promises elite dementia care by pairing a private provider with a charity. But does this innovative model create a two-tiered system?

As global rules on chemicals and circularity tighten, law firm Bergeson & Campbell launches a blog to guide firms through the complex regulatory maze.

Intouch Insight's "gold standard" study names its top operator finalists. How data-driven customer experience is redefining success for c-stores in 2026.

Activist investor SilverCape issues a stark ultimatum to PetMed Express, cutting its takeover bid from $4 to $3, blaming board inaction for value destruction.

A new AI tool promises to transcribe every word of an emergency call, turning chaos into data. But in a world of life and death, can we trust the algorithm?